Imunon, Inc.
Imunon, Inc. (CLSN) Stock Overview
Explore Imunon, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
14.5M
P/E Ratio
-0.46
EPS (TTM)
$-3.97
ROE
-4.28%
CLSN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Imunon, Inc. (CLSN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.81.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.46 and a market capitalization of 14.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.